Vor Biopharma Inc. (VOR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 129.12M |
| Enterprise Value | -264.36M |
| P/E Ratio | 0.07 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -8.82 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.75 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | 2.73 |
| Return On Equity | -8.3 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -693.09M |
| Net Income | -695.98M |
| Diluted EPS | -70.5 |
Balance Sheet
| Total Cash | 481.55M |
| Total Cash/Share | 8.07 |
| Total Debt | 2.81M |
| Total Debt/Equity | -0.02 |
| Current Ratio | 13.5 |
| Book Value Per Share | -2.3 |
Price History
| 52-Week Change | 105.96 |
| 52-Week High | 26 |
| 52-Week Low | 6.5 |
| Moving Average 50 Days | 20.25 |
| Moving Average 200 Days | 17.45 |
Statistics
| Average Volume | 941,578 |
| Shares Outstanding | 54.19M |
| % Held by Institutions | 89.55 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | September 19, 2025 |
AD
